Trial intelligence / Profile preview

Intrapleural fibrinolytic therapy with urokinase in refractory intrathoracic infection

jRCTs031180292Completed

Start
Oct 2018
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of urokinase in Intrathoracic infection and pleural abscess. Primary endpoint: Cure without surgery during hospitalization. Started Oct 2018; status: completed.

02

Drugs

urokinase
03

Conditions

Intrathoracic infectionpleural abscess

Beyond the preview

Go deeper on jRCTs031180292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call